tirzepatide gip/glp-1 vs. Semaglutide: What You Should Know The Novel Dual GIP and

The once-weekly dosing frequency not only offers convenience for patients but also more effectively manages blood glucose levels and weight

One of the major trials of tirzepatide (the active ingredient in Zepbound and Mounjaro ) showed participants losing an average of 15%--21% of their body weight over a period of 72 weeks, with more weight loss in those taking the highest dose of the drug

The best places to inject, and the recommended areas, are the abdomen (belly), thigh, or upper arm

The Mounjaro products are pre-filled single-dose pens (2.5 mg/0.5 mL, 5 mg/0.5 mL, 7.5 mg/0.5 mL, 10 mg/0.5 mL, 12.5 mg/0.5 mL, and 15 mg/0.5 mL), which were approved for commercial sale in May 2022 (NDA 215866) and added to the drug shortage list in December 2022 due to high demand

They are usually mild and improve as eating and hydration stabilise